
[Expand/Collapse all sections]Expand all

For information on how to process a PBS Authority, see Processing
Complex Authority Required Listings. Contact Local Peer Support (LPS) if
unsure of how to action an application.

Relapsed or refractory Hodgkin lymphoma (HL) quick reference

+-----------+-----------+-----------+-----------+-----------+-----------+
| Res       | Authority | PA        | P         | P         | P         |
| trictions | level and | a         | rocessing | rescriber | rescriber |
|           | section   | ssessment | system    | type      | s         |
|           |           |           |           |           | elf-serve |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Initial   | Written   | No        | OPA       | Not       | Yes       |
|           |           |           |           | specified |           |
| PB205     | E         |           |           |           |           |
|           | lectronic |           |           |           |           |
|           |           |           |           |           |           |
|           | S100:     |           |           |           |           |
|           |           |           |           |           |           |
|           | br        |           |           |           |           |
|           | entuximab |           |           |           |           |
|           | vedotin   |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| C         | Telephone | No        | OPA       | Not       | Yes       |
| ontinuing |           |           |           | specified |           |
|           | E         |           |           |           |           |
|           | lectronic |           |           |           |           |
|           |           |           |           |           |           |
|           | S100:     |           |           |           |           |
|           |           |           |           |           |           |
|           | br        |           |           |           |           |
|           | entuximab |           |           |           |           |
|           | vedotin   |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Initial   | St        | No        | OPA       | Not       | N/A       |
|           | reamlined |           |           | specified |           |
|           |           |           |           |           |           |
|           | S100:     |           |           |           |           |
|           |           |           |           |           |           |
|           | pemb      |           |           |           |           |
|           | rolizumab |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| C         | St        | No        | OPA       | Not       | N/A       |
| ontinuing | reamlined |           |           | specified |           |
|           |           |           |           |           |           |
|           | S100:     |           |           |           |           |
|           |           |           |           |           |           |
|           | pemb      |           |           |           |           |
|           | rolizumab |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+

                                   

-   Services Australia ABN 90 794 605 008 
